A Crowd Sourcing Platform for Patients With Cancer

• Sponsor: All4Cure (Industry)
• Overall Status: Recruiting
• CT.gov ID: NCT03530826
• Collaborator: (none)
• Enrollment: 5,000
• Location: 1
• Anticipated Duration (Months): 117.2
• Patients Per Site Per Month: 42.7

Study Details

Study Description

Brief Summary

All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.

Condition or Disease	Intervention/Treatment	Phase
Cancer	Other: No intervention

Detailed Description

The core hypothesis tested by this study is that engaging researchers, clinicians and patients in an online knowledge sharing platform will enable patients to better understand cancer, better inform treatment decisions made by oncologists and accelerate cancer research. Leftover samples from patients with cancer (blood, bodily fluids and/or tissues collected for clinical purposes) will be obtained and sent for various types of analyses and results will be shared on the All4Cure website.

Study Design

• Study Type: Observational [Patient Registry]
• Anticipated Enrollment: 5000 participants
• Observational Model: Other
• Time Perspective: Prospective
• Official Title: A Crowd Sourcing Platform for Patients With Cancer
• Actual Study Start Date: Apr 26, 2018
• Anticipated Primary Completion Date: Jan 31, 2028
• Anticipated Study Completion Date: Jan 31, 2028

Outcome Measures

Primary Outcome Measures

1. Change in tumor tissue molecular profiles [6 years]

   Profiles of pre- and post-treatment tumor tissue will be compared.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Have been diagnosed with cancer.

• Be under the care of a physician.

• Be 18 years of age or older.

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	All4Cure	Seattle	Washington	United States	98136

Sponsors and Collaborators

• All4Cure

Investigators

• Principal Investigator: Carl A Blau, MD, All4Cure

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Carl Anthony Blau, MD, Principal Investigator, All4Cure
• ClinicalTrials.gov Identifier: NCT03530826
• Other Study ID Numbers: All4Cure01
• First Posted: May 21, 2018
• Last Update Posted: Jul 21, 2021
• Last Verified: Jul 1, 2021

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Jul 21, 2021